Authors:
Yokosuka, O
Kojima, H
Imazeki, F
Tagawa, M
Saisho, H
Tamatsukuri, S
Omata, M
Citation: O. Yokosuka et al., Spontaneous negativation of serum hepatitis C virus RNA is a rare event intype C chronic liver diseases: analysis of HCV RNA in 320 patients who were followed for more than 3 years, J HEPATOL, 31(3), 1999, pp. 394-399
Authors:
Kojima, H
Yokosuka, O
Kato, N
Shiina, S
Imazeki, F
Saisho, H
Shiratori, Y
Omata, M
Citation: H. Kojima et al., Quantitative evaluation of telomerase activity in small liver tumors: analysis of ultrasonography-guided liver biopsy specimens, J HEPATOL, 31(3), 1999, pp. 514-520
Authors:
Kawai, S
Yokosuka, O
Kanda, T
Imazeki, F
Maru, Y
Saisho, H
Citation: S. Kawai et al., Quantification of hepatitis C virus by TaqMan PCR: Comparison with HCV Amplicor Monitor assay, J MED VIROL, 58(2), 1999, pp. 121-126
Authors:
Honda, A
Yokosuka, O
Ehata, T
Tagawa, M
Imazeki, F
Saisho, H
Citation: A. Honda et al., Detection of mutations in the enhancer 2/core promoter region of hepatitisB virus in patients with chronic hepatitis B virus infection: Comparison with mutations in precore and core regions in relation to clinical status, J MED VIROL, 57(4), 1999, pp. 337-344
Authors:
Yoshida, H
Shiratori, Y
Moriyama, M
Arakawa, Y
Ide, T
Sata, M
Inoue, O
Yano, M
Tanaka, M
Fujiyama, S
Nishiguchi, S
Kuroki, T
Imazeki, F
Yokosuka, O
Kinoyama, S
Yamada, G
Omata, M
Citation: H. Yoshida et al., Interferon therapy reduces the risk for hepatocellular carcinoma: Nationalsurveillance program of cirrhotic and noncirrhotic patients with chronic hepatitis C in Japan, ANN INT MED, 131(3), 1999, pp. 174